We are live on ! Find out more
MED icon

Medifast

133 hedge funds and large institutions have $314M invested in Medifast in 2016 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 61 increasing their positions, 38 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 38

13% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 16

6% more capital invested

Capital invested by funds: $297M → $314M (+$17.3M)

4.85% more ownership

Funds ownership: 83.06%87.91% (+4.8%)

2% more funds holding

Funds holding: 131133 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $10K

Holders
133
Holders Change
+2
Holders Change %
+1.53%
% of All Funds
3.53%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
18
Increased
61
Reduced
38
Closed
16
Calls
Puts
$10K
Net Calls
-$10K
Net Calls Change
+$1.38M

MED Hedge Fund Activity: Q1 2016 in Review

133 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q1 2016, worth a combined $314M — up 5.8% from $297M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new MED positions and 16 closed out — a net gain of 2 holders — while 61 added to existing stakes and 38 trimmed.

The largest buyer was Kennedy Capital Management, adding an estimated $4.95M. The largest seller was Morgan Stanley, cutting an estimated $3.18M.

  • 133 institutional investors held Medifast (MED) as of Q1 2016, up from 131 in Q4 2015.
  • Funds reported $314M of Medifast stock for Q1 2016, up 5.8% quarter-over-quarter.
  • 18 funds opened new Medifast positions in Q1 2016 and 16 closed out, a net change of +2 holders.
  • The largest Medifast buyer in Q1 2016 was Kennedy Capital Management, an estimated $4.95M added.
  • The largest Medifast seller in Q1 2016 was Morgan Stanley, an estimated $3.18M sold.

Based on aggregated 13F filings for Q1 2016.